Smith & Nephew

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics; Sports Medicine and ENT; and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies and ENT. The Advanced Wound Management segment comprises advanced wound care, advanced wound bioactives and advanced wound devices businesses. The company was founded by Thomas James Smith in 1856 and is headquartered in Watford, the United Kingdom.

Earnings data Q4 2019

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

Smith & Nephew plc (SNN) CEO Roland Diggelmann on Q4 2019 Results - Earnings Call Transcript

The JOURNEY II UK development is expected to provide a major impetus to Smith & Nephew's (SNN) Orthopedics segment.

Smith & Nephew's JOURNEY II UK Knee System Executes Surgeries

Smith & Nephew's (SNN) announces positive study outcomes for REGENETEN.

Smith & Nephew's Study Outcomes for REGENETEN Encouraging

Its chief executive's sudden exit sent the stock reeling.

Why Shares of Smith & Nephew Fell 10.2% in October

Smith & Nephew PLC (SNN) Management on Q3 2019 Results - Earnings Call Transcript

Smith+Nephew Plc  Chief Executive Namal Nawana is stepping down after just 17 months in the role after becoming dissatisfied with his salary at the medical device maker.

Smith+Nephew CEO steps down over pay, ex-Roche Diagnostics chief to take over

This can be considered a major step in Smith & Nephew's (SNN) commitment toward strengthening its Global Sports Medicine and ENT segment.

Smith & Nephew's (SNN) STITCH Study Outcome Encouraging

Smith & Nephew (SNN) has been gaining from several positive developments of late.

Smith & Nephew (SNN) Hits a 52-Week High: What's Driving It?

Smith & Nephew PLC (SNN) CEO Namal Nawana on Q2 2019 Results - Earnings Call Transcript

With Smith & Nephew's (SNN) buyout of Atracsys, the latter's fusionTrack 500 optical tracking camera will be a core enabling technology for the company's next-generation robotics platform.

Smith & Nephew Acquires Atracsys, Expands Robotic Portfolio

The transaction by Smith & Nephew (SNN), besides the business purchase, comprises certain intangible assets and the orthopaedic Brainlab salesforce.

Smith & Nephew (SNN) Buys Brainlab, Braces Robotic Ecosystem

Smith & Nephew PLC (SNN) CEO Namal Nawana on Q1 2019 Results - Earnings Call Transcript

Smith & Nephew has been gaining investor confidence on consistently positive results.

Here's Why You Should Invest in Smith & Nephew Now

Osiris Therapeutics

On March 12, 2019, Osiris Therapeutics disclosed that Smith & Nephew agreed to acquire the company for $660 million.

News for Smith & Nephew Stock (SNN)